Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis
暂无分享,去创建一个
Merlin C. Thomas | Merlin C Thomas | R. MacIsaac | D. Power | G. Jerums | M. Cooper | K. Sourris | G. Ramm | J. Forbes | M. Ryan | D. Thorburn | B. Drew | I. Trounce | Tuong-Vi Nguyen | S. McGee | K. Walder | P. Gregorevic | M. Coughlan | D. Henstridge | A. Genders | N. V. Van Bergen | E. Ekinci | H. Qian | Adrienne Laskowski | M. Herman-Edelstein | L. Gallo | A. Skene | S. Tan | B. Harcourt | S. Penfold | G. Higgins | V. Thallas‐Bonke | Portia M Robb | Xiaonan W. Wijeyeratne | M. Thomas | Brooke E. Harcourt | M. Cooper
[1] Y. Kanwar,et al. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. , 2015, Journal of the American Society of Nephrology : JASN.
[2] Kumar Sharma,et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.
[3] R. Touyz,et al. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.
[4] K. Tory,et al. Activating HSP72 in Rodent Skeletal Muscle Increases Mitochondrial Number and Oxidative Capacity and Decreases Insulin Resistance , 2014, Diabetes.
[5] V. D’Agati,et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. , 2014, The Journal of clinical investigation.
[6] E. Rugarli,et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission , 2014, The Journal of cell biology.
[7] S. McGee,et al. Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action , 2014, Molecular metabolism.
[8] A. Tobar,et al. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy , 2014, Journal of Lipid Research.
[9] Songming Huang,et al. Mitochondrial dysfunction in the pathophysiology of renal diseases. , 2014, American journal of physiology. Renal physiology.
[10] T. Ideker,et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. , 2013, Journal of the American Society of Nephrology : JASN.
[11] Y. Yoon,et al. Mitochondrial morphology in metabolic diseases. , 2013, Antioxidants & redox signaling.
[12] M. Cooper,et al. Deficiency in mitochondrial complex I activity due to Ndufs6 gene trap insertion induces renal disease. , 2013, Antioxidants & redox signaling.
[13] B. Westermann. Bioenergetic role of mitochondrial fusion and fission. , 2012, Biochimica et biophysica acta.
[14] P. Nicholls,et al. Lentiviral transduction of rat Sertoli cells as a means to modify gene expression , 2012, Spermatogenesis.
[15] W. Hsu,et al. Transgenic Control of Mitochondrial Fission Induces Mitochondrial Uncoupling and Relieves Diabetic Oxidative Stress , 2012, Diabetes.
[16] E. O'Neill,et al. Impaired complex-I-linked respiration and ATP synthesis in primary open-angle glaucoma patient lymphoblasts. , 2012, Investigative ophthalmology & visual science.
[17] P. Overbeek,et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. , 2012, Cell metabolism.
[18] M. Knip,et al. Advanced Glycation End Products Are Direct Modulators of β-Cell Function , 2011, Diabetes.
[19] S. McGee,et al. DHA Protects Against Zinc Mediated Alterations in Neuronal Cellular Bioenergetics , 2011, Cellular Physiology and Biochemistry.
[20] I. Sevrioukova. Apoptosis-inducing factor: structure, function, and redox regulation. , 2011, Antioxidants & redox signaling.
[21] T. Dawson,et al. Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos) , 2011, Science Signaling.
[22] M. Knip,et al. Advanced Glycation End Products Are Direct Modulators of b -Cell Function , 2011 .
[23] R. Youle,et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells , 2010, The Journal of cell biology.
[24] Benedikt Westermann,et al. Mitochondrial fusion and fission in cell life and death , 2010, Nature Reviews Molecular Cell Biology.
[25] T. Mak,et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.
[26] P. Bénit,et al. Life with or without AIF. , 2010, Trends in biochemical sciences.
[27] M. Zeviani,et al. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. , 2010, American journal of human genetics.
[28] Merlin C. Thomas,et al. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. , 2010, American journal of physiology. Renal physiology.
[29] W. Sivitz,et al. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. , 2010, Antioxidants & redox signaling.
[30] Z. Dong,et al. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. , 2009, The Journal of clinical investigation.
[31] M. Cooper,et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. , 2009, Journal of the American Society of Nephrology : JASN.
[32] A. Kribben,et al. Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatinine. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] P. Bénit,et al. The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes , 2008, PloS one.
[34] M. Cooper,et al. Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes , 2008, Diabetes.
[35] M. Cooper,et al. Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway , 2008, Diabetes.
[36] R. Youle,et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. , 2008, Brain : a journal of neurology.
[37] J. Bonventre,et al. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. , 2007, Journal of the American Society of Nephrology : JASN.
[38] M. Lazarou,et al. Analysis of mitochondrial subunit assembly into respiratory chain complexes using Blue Native polyacrylamide gel electrophoresis. , 2007, Analytical biochemistry.
[39] R. Unwin,et al. The Not So ‘Mighty Chondrion’: Emergence of Renal Diseases due to Mitochondrial Dysfunction , 2006, Nephron Physiology.
[40] S. Fukuhara,et al. Health-Related Quality of Life of Predialysis Patients with Chronic Renal Failure , 2006, Nephron Clinical Practice.
[41] David S. Park,et al. Dissociating the dual roles of apoptosis‐inducing factor in maintaining mitochondrial structure and apoptosis , 2006, The EMBO journal.
[42] K. Mihara,et al. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space , 2005, The EMBO journal.
[43] P. Bénit,et al. AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.
[44] C. Leeuwenburgh,et al. Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[45] P. Frachon,et al. Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. , 2002, Molecular biology of the cell.
[46] Wayne N. Frankel,et al. The harlequin mouse mutation downregulates apoptosis-inducing factor , 2002, Nature.
[47] J. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.
[48] H. Schägger. Respiratory Chain Supercomplexes , 2001, IUBMB life.
[49] G. Kroemer,et al. NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor* , 2001, The Journal of Biological Chemistry.
[50] Ruedi Aebersold,et al. Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.
[51] R. Atkins,et al. The enhancement of aminonucleoside nephrosis by the co-administration of protamine. , 1987, Kidney international.
[52] S. Soltoff,et al. ATP and the regulation of renal cell function. , 1986, Annual review of physiology.